Jubilant

Jubilant Pharmova arm to invest $300 mn in US to double injectable capacity

Jubilant HollisterStier LLC, an arm of Jubilant Pharmova Ltd, will invest USD 300 million by FY28 in the US to double its sterile injectable manufacturing capacity, with President Donald Trump's tariffs accelerating its original plans, company CEO - CDMO Sterile Injectables, Chris Preti, said on Friday. The company has launched its new sterile fill and finish line -- the third at its Spokane manufacturing facility in Washington, US, set up at an investment of USD 132 million, Preti told PTI. "Our overall investment is almost USD 300 million at our Spokane facility. This is the first of the two phases ... This USD 132 million is phase one, which is our third line," he said. Preti further said, "This will bring an additional 50 per cent of capacity in the US that is available now and then, the additional investment, totaling USD 300 million in all, will be actually completed by the end of fiscal year 2028 which will bring on another 50 per cent of additional capacity." On the company

Jubilant Foodworks Q1 results: PAT rises to 64% on strong delivery growth

The company added that delivery channel revenue was up by 24.6 per cent and dine-in channel revenue rose 2.5 per cent, mainly driven by lunch-hour meals

Jubilant gets $600 mn boost from Goldman for Coca-Cola India stake buy

Convertible preference shares is one of the many ways companies can raise capital to fund their operations and expansion

'Business as usual': Indian firms brush off Türkiye tensions

None of the Indian firms - including Jubilant FoodWorks, Mahindra & Mahindra, and Dabur India - responded to emailed requests for comment

Jubilant pulls ahead of KFC, McDonald's as Q4 earnings near: Analysts

Jubilant has already flagged a 12.1% increase in like-for-like sales in India in its quarterly update, which analysts say has benefited from its focus on online sales

Union Bk, Jubilant FoodWorks must have stocks for your portfolio. Check why

Union Bank stock has been forming a 'Higher Top Higher Bottom' structure and has been a relative outperformer within the PSU Banking space in last couple of weeks, says Ruchit Jain of MOFSL.

Jubilant Foods aims 3,000 Domino's stores, 250 Popeyes outlets in 3 years

Leading QSR chain operator Jubilant Foods is looking to expand its pizza chain Domino's presence to 3,000 stores and around 250 outlets of US-based Fried Chicken brand Popeyes over the next three years, its CEO and MD Sameer Khetarpal said on Thursday. The Jubilant Bhartia Group company is focusing on smaller tier III towns and entering into new markets for Domino's. For Popeyes, it will focus on metro and tier II cities. "We will be growing in both brands. I think, our focus and priority is Popeyes. We believe Popeyes will grow faster than the other brands," Khetarpal told PTI. Currently, Jubilant Foods Ltd (JFL) operates around 2,100 Domino's outlets, the second largest network of the US-based multinational pizza restaurant chain globally. For Popeyes, Khetarpal said JFL is currently operating around 60 stores and will keep on adding up to 50 stores every year and have nearly 200 to 250 stores over the three years. "We go tier I, tier II for sure like we already are present in

Nuvama bets on QSR, jewellery sectors post Q3, picks Jubilant, Titan, Trent

Nuvama has picked Jubilant, Trent, V-Mart, Titan, and Aditya Vision as its top bets going forward, highlighting their strong performances and promising outlook

Jubilant Biosys expands global footprint with acquisition in France

This acquisition marks a significant step in Jubilant Biosys' global strategy, providing a foothold in Europe's expanding pharmaceutical and biotech ecosystem

Jubilant FoodWorks Q3 results: PAT falls 35% to Rs 42.9 cr, revenue up 56%

Jubilant reported profit of Rs 42.91 crore ($4.94 million) for the quarter ended December 31, compared to a year-ago profit of Rs 65.709 crore

Jubilant likely to raise Rs 5,500 cr via bonds for Coke bottling biz deal

Banking sources said the group is exploring the prospect of issuing debentures

Jubilant Pharmova Q3 result: Profit rises 51% to Rs 101 cr on strong demand

Revenue rose 9 per cent to Rs 1,814 crore, lifted by the radiopharma segment's nearly 12 per cent growth this quarter

Jubilant Ingrevia Q3 results: PAT jumps 54% to Rs 59.38 cr, sales rise 9%

Specialty chemicals and life science ingredient maker Jubilant Ingrevia on Tuesday reported an increase of 54 per cent in its net profit at Rs 59.38 crore for the third quarter ended December 2024. It had posted a net profit of Rs 38.56 crore in the October-December quarter a year ago, according to a regulatory filing from the Jubilant Bhartia Group firm. Its sales were up 8.91 per cent to Rs 1,046.06 crore during the quarter under review as compared to Rs 960.45 crore in the corresponding period a year ago. Total expenses of Jubilant Ingrevia in the December quarter were up 5.48 per cent to Rs 970.63 crore. Jubilant Ingrevia's total income, including other income, was Rs 1,056.20 crore, up 8.3 per cent year-on-year in the December quarter. Chairman Shyam S Bhartia and Co-Chairman Hari S Bhartia said the significant year-on-year growth for this quarter is "attributed to the enhanced performance of our Specialty Chemicals and Nutrition businesses, as well as to the benefits derived

Religare Broking's Ajit Mishra says buy these pharma, QSR and auto stocks

Nifty Today, Stocks to Buy Today: The Nifty50 index has now entered its second week of consolidation, and current indicators suggest that this trend is likely to persist

Jubilant Bhartia Group to acquire 40% stake in Coca-Cola's bottler HCCB

Reports peg the deal at around Rs 12,500 crore

Jubilant Ingrevia hits 52-wk high as arm inks pact with leading agrochem co

Jubilant Ingrevia said its subsidiary Jubilant Agro Sciences will produce and supply an agro intermediate product for one of the key agro actives produced by the multi-billion dollar agrochem company

Nuvama ups target on Jubilant Ingrevia, retains 'buy'; check details

A likely recovery in the agrochemicals sector, combined with early progress in the diketene business shall drive margins, according to Nuvama

Jubilant Q1 result: Domino's India franchisee reports 2x rise in profit

To spur demand Jubilant offered free home delivery and value deals such as meals for Rs 99 ($1.18), in a quarter that coincided with the T20 Cricket World Cup and school summer vacations

Jubilant to deliver extra cheese on value, with slice of pizza recovery

Domino's Indian franchise gains steam as pizza outpaces burger rivals amid shifting market dynamics

Q4 Results Today: Sun Pharma, Grasim, Nykaa Among 32 Firms to Post Earnings

Company Results Q4 FY24: Jubilant, Ramco Cements, NIIT Learning also anticipated to release fourth quarter earnings on May 22